Comparative immunogenicity of hepatitis B vaccine administered into the ventrogluteal area and anterolateral thigh in infants
Authors:
- 1 August 2002
- journal article
- clinical trial
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 38 (4) , 393-396
Abstract
Objective: To compare the immunological response of hepatitis B vaccine given by intramuscular injection into the anterolateral thigh and ventrogluteal site of infants up to 10 months old at initiation of vaccination. Methods: An open, randomized study of 200 healthy infants recruited from a single practice in a small regional town in New South Wales was carried out. Infants were vaccinated with hepatitis B vaccine (Engerix‐B 10 µg) using a 0 months, 1 month, 6 months regimen, with venous blood being collected from children 4−6 weeks after the last dose of vaccine for quantitative determination of hepatitis B surface antibody (anti‐HBs) titre. Infants with anti‐HBs titre ≥ 100mIU/mL were considered to be ‘good’ responders and were unlikely to acquire clinically significant hepatitis B infection. Infants with anti‐HBs titre < 100mIU/mL were considered to be ‘poor’ responders and were given a booster dose of Engerix‐B 20 µg; serology was repeated for anti‐HBs titre 2−3 months after this injection. Results: Quantitative anti‐HBs titre was obtained from 177 infants: 171 4−6 weeks after the last dose of vaccine; 87 at the ventrogluteal site (46 boys, 41 girls); and 84 at the anterolateral thigh site (38 boys, 46 girls). Good antibody response (anti‐HBs titre ≥ 100mIU/mL) was not significantly different for the two sites (ventrogluteal 96.6%, anterolateral thigh 93.2%), and antibody geometric mean titres (GMT) for anti‐HBs were comparable for the two sites (ventrogluteal 2071.2 ± 5.8mIU/mL, anterolateral thigh 2073.2 ± 5.2mIU/mL). Conclusion: The ventrogluteal and anterolateral thigh vaccination sites in infants are immunologically comparable for hepatitis B vaccine. Presumably the variance of this study with studies of adults reflected the uniform injection of vaccine antigen into muscle tissue in infants.Keywords
This publication has 22 references indexed in Scilit:
- Predictors of adverse events after the administration of acellular and whole-cell diphtheria-tetanus-pertussis vaccinesVaccine, 1998
- Comparison study of the immunogenicity and safety of 5- and 10-μg dosages of a recombinant hepatitis B vaccine in healthy childrenThe Pediatric Infectious Disease Journal, 1996
- Comparative safety and immunogenicity of two recombinant hepatitis B vaccines given to infants at two, four and six months of ageThe Pediatric Infectious Disease Journal, 1996
- Safety and immunogenicity of a recombinant hepatitis B vaccine administered to infants at 2, 4 and 6 months of ageVaccine, 1996
- Duration of hepatitis B antibody response in children immunised with hepatitis B and compulsory vaccinesEuropean Journal of Epidemiology, 1995
- The vaccine adverse event reporting system (VAERS)Vaccine, 1994
- Administration of rabies vaccine in the gluteal area: a continuing problemArchives of internal medicine (1960), 1991
- Clinical experience with hepatitis B vaccinesAmerican Journal of Infection Control, 1989
- Sciatic nerve injury following misplaced gluteal injectionThe Journal of Pediatrics, 1970
- Postinjection sciatic nervepalsies in infants and childrenThe Journal of Pediatrics, 1961